Renaissance Technologies LLC Takes Position in Bionano Genomics, Inc. (NASDAQ:BNGO)

Renaissance Technologies LLC acquired a new position in Bionano Genomics, Inc. (NASDAQ:BNGO) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 158,300 shares of the company’s stock, valued at approximately $46,000. Renaissance Technologies LLC owned about 8.12% of Bionano Genomics at the end of the most recent quarter.

Separately, Carret Asset Management LLC raised its holdings in Bionano Genomics by 39.9% during the fourth quarter. Carret Asset Management LLC now owns 119,000 shares of the company’s stock valued at $34,000 after acquiring an additional 33,945 shares during the period. Institutional investors own 11.35% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on BNGO shares. HC Wainwright assumed coverage on Bionano Genomics in a research report on Wednesday, April 9th. They set a “buy” rating and a $10.00 target price for the company. Scotiabank boosted their target price on shares of Bionano Genomics from $1.00 to $4.00 and gave the stock a “sector perform” rating in a report on Wednesday, April 2nd.

Bionano Genomics Stock Performance

Shares of NASDAQ BNGO opened at $3.69 on Thursday. The stock has a market cap of $11.44 million, a price-to-earnings ratio of -0.03 and a beta of 2.36. The company has a 50 day simple moving average of $3.68 and a two-hundred day simple moving average of $9.28. The company has a current ratio of 1.43, a quick ratio of 0.99 and a debt-to-equity ratio of 0.07. Bionano Genomics, Inc. has a 12 month low of $2.68 and a 12 month high of $72.60.

Bionano Genomics Profile

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.